NanoScout

NanoScout provides nano-detection technologies and services, offering scalable solutions for companies of all sizes. NanoScout is a software product that allows multiple industries to find, solve, and diagnose problems at the nano scale. With its cloud-based artificial intelligence, the company has the ability to learn and create specific algorithmic solutions for each customer. Using a single pathogen's nano-morphology, NanoScout is able to perform high-end diagnostics and quality assurance. Through the use of its cloud-based technology and a robust chemical protocol, the company successfully diagnoses and detects problems on the nano scale. By combining cloud AI technology and proprietary sample preparation protocols, it is able to detect the minute details of pathogens and products to detect everything from impurities to infection. NanoScout's mission is to enable a new age of fast, accurate, and low-cost testing of nano-morphology for diagnostics and quality assurance.

NanoScout was founded in 2020 by Sam Weitzman (Co-founder & Co-CEO), Yaakov Diminsky (Former Co-founder & Co-CEO), Yohan Ouzan-Van Der Mark (Co-founder & COO).

NanoScout operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Platforms & Interfaces, Software, Artificial Intelligence, Data Storage, Cloud. Target customers: Enterprise & Professional Services, Enterprises, Education, Higher Education, Healthcare & Life Sciences, Healthcare, Providers.

NanoScout is based in Tel Aviv, Israel, Center District.